ABSTRACT
In the era of fixed appliances, some orthodontic practitioners seem to forget about functional therapy. Functional appliances are the only capable of orthopedically changes during the growth spurt. Activators of all types, classic or opened, are elected appliances in growing subjects with class II/1 anomalies. The appropriate case selection, along with patient compliance, lead to improved facial aesthetic and dental occlusion, at affordable prices. With this case presentation, we want to show our protocol in the management of these cases.
Subject(s)
Cephalometry , Malocclusion, Angle Class II/pathology , Malocclusion, Angle Class II/rehabilitation , Malocclusion, Angle Class I/pathology , Malocclusion, Angle Class I/rehabilitation , Orthodontics, Corrective , Child , Esthetics, Dental , Humans , Male , Malocclusion, Angle Class I/physiopathology , Malocclusion, Angle Class II/physiopathology , Mandible/pathology , Maxilla/pathology , Orthodontic Appliance Design , Orthodontics, Corrective/instrumentation , Orthodontics, Corrective/methods , Treatment OutcomeABSTRACT
UNLABELLED: Anchorage represents a great issue that challenged orthodontists all over the years. Nowadays, with the use of microimplants, it has become possible even to induce complex teeth movements. AIM: To present a clinical case in which mesialisation of upper second molars was performed by the means of using miniimplants. RESULTS: The present case shows how a bilateral mesialization of upper second molars using skeletal anchorage was performed by orthodontic treatment using fixed appliances and miniimplants. CONCLUSION: The placing site of the miniimplants plays a huge role in the moments of force produced and delivered to the teeth, thus influencing tooth movement. Miniimplants increase tooth movement control, by the use of skeletal anchorage. The success of their usage depends upon its good primary stabilization and a judicious loading.
Subject(s)
Malocclusion/therapy , Molar , Orthodontic Anchorage Procedures/methods , Adolescent , Dental Implants , Female , Humans , Malocclusion/surgery , Molar/surgery , Orthodontic Anchorage Procedures/instrumentation , Orthodontic Appliances , Orthodontic Wires , Orthodontics, Corrective/methods , Treatment OutcomeABSTRACT
The aim of the study was to assess the normal and synostosed coronal cranial sutures morphology at an ultrastructural level. Different operative specimens of human coronal sutures were collected. Three-dimensional reconstruction of the microcomputed tomography (micro-CT) slices were obtained and compared with the representative histologic sections. The micro-CT scanning provides a three-dimensional view of the sutures at a microscopical level thus allowing to establish the stage of development and the bone morphology. The micro-CT has the advantage of being able to image more slices than the normal histology without any damage to the analyzed specimens. Micro-CT is a powerful tool in the craniofacial area that allows us to obtain many structure-orientated slices and in conjunction with the histologic sections provides an overall thorough quantitative analysis of all cranial sutures.
Subject(s)
Cranial Sutures/anatomy & histology , Cranial Sutures/diagnostic imaging , Imaging, Three-Dimensional , X-Ray Microtomography , Humans , Image Processing, Computer-Assisted , Imaging, Three-Dimensional/methods , Infant , Male , Skull/anatomy & histology , Skull/diagnostic imagingABSTRACT
UNLABELLED: The interdisciplinary, complex therapeutic protocol of the cleft lip and palate patients, applied in the Clinic of Cranio-Maxillo-Facial Surgery of "I. Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, involves the morphologic reconstruction as well as the functional rehabilitation. Functional rehabilitation is the aspect, which gives the esthetics, social and familial integration of the patient, offering good quality of life. METHOD: In the current study, a new method and concept of improving the phonetic function in the primary and secondary surgical steps, with the effect on muscle and bone, is presented. The new surgical techniques used comprise of the surgery of the levator veli palatini using the method designed by Sader, and bone distraction, during the same surgical procedure. The assessment of the phonetic results was performed using the NARSOM test. RESULTS: Following up the results of the techniques mentioned above, we consider that they improve extremely well the morphological status, while giving a functional and physiological support to the patient. CONCLUSION: Thus, they offer optimal conditions for the future progress of functional rehabilitation using specific speech therapy methods.
Subject(s)
Cleft Lip/rehabilitation , Cleft Lip/surgery , Cleft Palate/rehabilitation , Cleft Palate/surgery , Plastic Surgery Procedures/methods , Child , Cleft Lip/therapy , Cleft Palate/therapy , Humans , Interdisciplinary Communication , Palatal Muscles/surgery , Palate, Hard/surgery , Quality of Life , Speech Articulation Tests , Speech Therapy/methods , Treatment OutcomeABSTRACT
This case report highlights the possibility of a non extraction orthodontic treatment, surgically assisted, in a Class II Division 1 malocclusions in order to reduce maxillary protrusion prior to the surgical advancement of the mandible for the correction of the skeletal deficiency. The combined orthodontic-surgical approach optimizes the profile while allowing the settling of a Angle Class I occlusion at the end of the entire treatment sequence.
Subject(s)
Malocclusion, Angle Class II/therapy , Malocclusion, Angle Class I/therapy , Mandibular Advancement , Orthodontics, Corrective/methods , Adolescent , Combined Modality Therapy , Esthetics, Dental , Humans , Male , Malocclusion, Angle Class I/surgery , Malocclusion, Angle Class II/surgery , Occlusal Adjustment , Orthodontic Appliances, Removable , Treatment OutcomeABSTRACT
This study evaluated the bioequivalence of a new Cyclosporine A microemulsion formulation in comparison to the reference market standard. Twenty-four adult healthy volunteers were randomised to receive the two Cyclosporin A microemulsion formulations, at a dose of 2.5 mg/kg, according to a cross-over design. Blood samples were taken before drug administration and at 12 points within 24 hours. Cyclosporine A whole blood concentrations were determined by HPLC. The pharmacokinetic parameters AUC0-t and AUC0-infinity were calculated by the trapezoidal rule, Cmax and Tmax were obtained directly from blood data. AUCs and Cmax were tested for bioequivalence after log transformation of data, differences for Tmax were evaluated by the rank test of Wilcoxon for paired data. The 90% confidence interval ratio between tested/reference drug was 0.98 for AUC0-t, 0.96 for AUC0-infinity and 1.01 for Cmax. All of them were within the range of bioequivalence. Tmax was 1.60 +/- 0.44 hours after test drug and 1.67 +/- 0.48 after reference drug (p = 0.27, Wilcoxon test). According to these results the two Cyclosporine A microemulsion formulations can be considered bioequivalent.
Subject(s)
Cyclosporine/administration & dosage , Cyclosporine/pharmacokinetics , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/pharmacokinetics , Adult , Biological Availability , Cross-Over Studies , Emulsions , Female , Humans , Male , Single-Blind MethodABSTRACT
The treatment of chronic viral hepatitis with Interferon has been introduced in clinical practice over the past decade an represents an important step in the management of those diseases. The data existing in literature are conflicting about the dose and period of treatment with Interferon, many treatment schedules being proposed. There are also a lot of markers used or proposed to be used to determine the response to treatment, their predicting efficacy being largely studied. The response to alpha-Interferon in a standard 6 month regimen in chronic hepatitis B, chronic hepatitis C and chronic hepatitis B and C is studied; alanine-aminotransferase (ALAT) and aspartate-aminotransferase (ASAT) are the markers used to determine the response to treatment.
Subject(s)
Antiviral Agents/administration & dosage , Hepatitis B, Chronic/drug therapy , Hepatitis C, Chronic/drug therapy , Interferon-alpha/administration & dosage , Adolescent , Adult , Aged , Alanine Transaminase/blood , Alanine Transaminase/drug effects , Antiviral Agents/adverse effects , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/drug effects , Biomarkers/blood , Child , Female , Hepatitis B, Chronic/blood , Hepatitis C, Chronic/blood , Humans , Injections, Subcutaneous , Interferon-alpha/adverse effects , Male , Middle Aged , Prospective Studies , Time FactorsABSTRACT
Previously these authors and others demonstrated frequent homozygous deletions of the chromosome 9p-localized class I interferon (IFN) gene cluster in glioblastoma tumors and cell lines. To investigate the biological effects of class I IFN gene transfer and constitutive expression in glioblastoma cells devoid of this gene cluster, the authors have developed a stable IFNalpha "transfectant" of the cell line U118. The expression of IFNalpha protein in the U118 transfectant clone is associated with decreased levels of DNA synthesis exhibited by cultures of transfected cells, reduced colony-forming ability in soft agar, and loss of tumorigenicity in athymic nude mice. To address the molecular consequences of constitutive IFNalpha synthesis, they examined the expression of four genes whose transcription has been shown to be responsive to IFN-mediated signal transduction and could be important to the observed antiproliferative and antitumor effects. Northern blot analysis revealed that changes in the levels of messenger (m)RNA for two of these genes, c-myc and mhc class I, are minor. However, mRNAs for oligoadenylate synthetase (OAS) as well as double-stranded RNA-activated protein kinase (PKR), which are not expressed in parental U118 cells, were constitutively expressed in IFNalpha transfectants. These results indicate a differential responsiveness among these four genes to constitutive IFNalpha expression, and suggest that the suppression of U118-transformed phenotypes by IFNalpha transfection may be mediated by the induction of specific IFN response genes thought to have a negative growth-regulatory function.
Subject(s)
2',5'-Oligoadenylate Synthetase/genetics , Brain Neoplasms/genetics , Gene Expression , Glioblastoma/genetics , Interferon-alpha/genetics , Protein Serine-Threonine Kinases/genetics , Transfection , Base Sequence , Gene Deletion , Humans , Molecular Sequence Data , RNA, Messenger/metabolism , Signal Transduction , eIF-2 KinaseABSTRACT
The use of visual evoked potentials in the detection of optic chiasma syndrome of tumoral etiology has been controversial in the literature. In our study the pattern visual evoked potentials (PVEP) were recorded in 22 healthy free volunteers and in 32 patients with optic chiasma syndrome (OCS) produced by tumors of the hypothalamic-pituitary area, mainly pituitary adenomas with suprasellar extension, proved by CT scan. The PVEP were recorded bilateral after monocular photic stimulation of each atropinized eye, in parallel with a complete ophthalmologic exam consisting in visual field, visual acuity and optic fundus. The main results showed that the latencies P100 recorded bilateral were correlated (p < 0.01) with the types of visual field deficiency, in each hemifield. The changes in P100 latency are more sensitive than the evolution of visual field deficiency by campimetry. The same correlation was observed between the "W" form of P wave with the visual field defect. A significant decrease (p < 0.05) of the amplitude of P100 was observed only if the visual acuity was less than 1/2. It is suggested that the PVEP is a reliable index of diagnosis and evolution for the optic chiasma syndrome aside the usual ophthalmologic exam.
Subject(s)
Evoked Potentials, Visual , Ophthalmology/methods , Optic Chiasm/physiopathology , Pituitary Neoplasms/physiopathology , Prolactinoma/physiopathology , Vision Disorders/diagnosis , Adolescent , Adult , Female , Humans , Male , Middle Aged , Pituitary Neoplasms/complications , Pituitary Neoplasms/diagnosis , Prolactinoma/complications , Prolactinoma/diagnosis , Vision Disorders/etiology , Vision Disorders/physiopathologyABSTRACT
The changes of total hemolytic complement (CH50), of C3 and C1q components and of the circulating immune complexes (CIC) were studied in a group of 112 patients with multiple sclerosis (MS) and in 50 controls. The attack was taken as a basis of observation. It was observed that in MS attacks CH50, C3 and C1q were decreased owing to the activation of the complement in the classical way. The CH50 values were found well enough correlated with C3 and C1q (r = 0.535) and respectively r = 0.497) and clearly correlated with the CIC values (r = 0.907). A sharp decrease of CH50 increases the probability of the appearance of an attack with slow remission and the probability of an attack with slow remission is the greater, the greater the increase of CIC values. Low CH50, C3 and C1q values correlated with high CIC values may be considered markers of severity in MS.
Subject(s)
Antigen-Antibody Complex/blood , Complement System Proteins/analysis , Multiple Sclerosis/immunology , Adolescent , Adult , Age Distribution , Complement C1q/analysis , Complement C3/analysis , Complement Hemolytic Activity Assay , Female , Humans , Male , Middle Aged , Multiple Sclerosis/epidemiology , Retrospective Studies , Romania/epidemiology , Sex DistributionABSTRACT
The authors have studied two groups of children from the City of Cluj. The first lot included 1212 children aged 6-7 years, and the second one included 616 children aged 12-13 years. The study consisted in an evaluation of the status of definitive molar teeth in the period which followed the eruption. The frequency of decay was 47.62% for the first molar tooth, and of 37.12% for the second molar. The intensity index was 22.45% and 11.10% respectively. Six years after the eruption the frequency of decay in the first molar tooth was 85.23%, and the intensity was 56.58%.
Subject(s)
Dental Caries/epidemiology , Child , Humans , Molar/pathology , Romania/epidemiologySubject(s)
Aromatic Amino Acid Decarboxylase Inhibitors , Levodopa/therapeutic use , Parkinson Disease/drug therapy , Adult , Aged , Cardiovascular Diseases/chemically induced , Drug Combinations , Drug Evaluation , Dyskinesia, Drug-Induced/etiology , Female , Gastrointestinal Diseases/chemically induced , Humans , Levodopa/adverse effects , Male , Mental Disorders/etiology , Middle AgedSubject(s)
Empty Sella Syndrome/diagnosis , Adolescent , Adult , Cerebrospinal Fluid Rhinorrhea/etiology , Empty Sella Syndrome/complications , Empty Sella Syndrome/etiology , Female , Headache/etiology , Humans , Middle Aged , Pneumoencephalography , Tomography, X-Ray Computed , Vision Disorders/etiologyABSTRACT
Four case reports are presented of patients who ate the meat of a hog inadvertently fed seed treated with fungicides containing ethyl mercury chloride. The clinical, electrophysiological, and toxicological, and in two of the patients the pathological data, showed that this organic mercury compound has a very high toxicity not only for the brain, but also for the spinal motoneurones, peripheral nerves, skeletal muscles, and myocardium.
Subject(s)
Cardiomyopathies/chemically induced , Ethylmercury Compounds/poisoning , Muscular Diseases/chemically induced , Nervous System Diseases/chemically induced , Adolescent , Brain/drug effects , Brain/pathology , Cardiomyopathies/pathology , Child , Female , Humans , Male , Middle Aged , Muscles/pathology , Muscular Diseases/pathology , Myocardium/pathology , Nervous System Diseases/pathology , Neural Conduction/drug effectsABSTRACT
Arginine vasotocin (AVT) or placebo were subcutaneously administered to 4 men at 22.00 and 01.00 h, along four nights, and polygraphic recordings were performed between 22.00 and 02.00 h during sleep. AVT significantly increased only the amount of rapid eye movement (REM) sleep (p less than 0.05), but did not influence the latency of the first REM sleep period. This effect of AVT was not dose dependent in the range between 2 and 12 microgram AVT. AVT or placebo were also intravenously injected or perfused to 10 normal adult subjects, at different times of the day, under clinical control. Doses between 2 microgram perfused 4 h and 12 microgram perfused 30 min, did not produce clinical signs of sleep. It is suggested that AVT is not a blood factor for inducing of slow waves sleep (SWS) or REM sleep in humans.